StreetInsider.com News Articles

Form SD GE HealthCare Technologi

Fri, 29 May 2026 08:25:00 -0400

si-local-file:///var/storage/secattach/20260529/26571026.html

Form SD GE HealthCare Technologi

Fri, 29 May 2026 08:25:00 -0400

si-local-file:///var/storage/secattach/20260529/26571026.html

Form 4 GE HealthCare Technologi For: May 22 Filed by: Lobo Kevin

Tue, 26 May 2026 18:45:00 -0400

si-local-file:///var/storage/secattach/20260526/26551766.html

Form 4 GE HealthCare Technologi For: May 22 Filed by: Lobo Kevin

Tue, 26 May 2026 18:45:00 -0400

si-local-file:///var/storage/secattach/20260526/26551766.html

Form 4 GE HealthCare Technologi For: May 22 Filed by: Lobo Kevin

Tue, 26 May 2026 18:45:00 -0400

si-local-file:///var/storage/secattach/20260526/26551766.html

University of Washington and GE HealthCare launch imaging research collaboration

Thu, 21 May 2026 06:56:14 -0400

The University of Washington Department of Radiology and GE HealthCare (NASDAQ: GEHC) announced a strategic research collaboration to advance computed tomography and molecular imaging technologies for cardiology, oncology and theranostics applications.

The partnership aims to automate workflows and accelerate clinical translation of medical imaging techniques. The collaboration focuses on two main areas: CT imaging advancement and molecular imaging with theranostics for personalized cancer care.

The CT program will pursue clinical evidence for spectral imaging technologies and optimize workflows through automation and software solutions. The molecular imaging component combines diagnostic imaging methods, AI-enabled software and radiopharmaceuticals to support precision cancer care and clinical

University of Washington and GE HealthCare launch imaging research collaboration

Thu, 21 May 2026 06:56:14 -0400

UBS Upgrades GE HealthCare (GEHC) to Neutral

Thu, 21 May 2026 03:06:15 -0400

UBS analyst Graham Doyle upgraded GE HealthCare (NASDAQ: GEHC) from Sell to Neutral with a price target of $69.00 (from $75.00).

The analyst comments: “GEHC shares have declined c.30% since January, which we attribute to concerns around new product execution, China exposure and inflationary pressures, leaving the stock back near IPO levels and trading on ~12x 2027E PE. We believe this valuation now appropriately reflects these key concerns, supporting our move to a Neutral rating (from Sell). However, we stop short of a more constructive stance as our forecasts remain below management's mid-term guidance (and consensus), and we see limited catalysts

UBS Upgrades GE HealthCare (GEHC) to Neutral

Thu, 21 May 2026 03:06:15 -0400

UBS analyst Graham Doyle upgraded GE HealthCare (NASDAQ: GEHC) from Sell to Neutral with a price target of $69.00 (from $75.00).

Form 4 GE HealthCare Technologi For: May 15 Filed by: Rackliffe Philip

Tue, 19 May 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260519/26521033.html

Form 4 GE HealthCare Technologi For: May 15 Filed by: Rackliffe Philip

Tue, 19 May 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260519/26521033.html

Form 4 GE HealthCare Technologi For: May 15 Filed by: Rackliffe Philip

Tue, 19 May 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260519/26521033.html

Form 4 GE HealthCare Technologi For: May 15 Filed by: Bankes Jeannette

Tue, 19 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260519/26520965.html

Form 4 GE HealthCare Technologi For: May 15 Filed by: Bankes Jeannette

Tue, 19 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260519/26520965.html

Form 4 GE HealthCare Technologi For: May 15 Filed by: Bankes Jeannette

Tue, 19 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260519/26520965.html

Form SCHEDULE 13G/A GE HealthCare Technologi Filed by: DODGE & COX

Thu, 14 May 2026 12:42:00 -0400

si-local-file:///var/storage/secattach/20260514/26492818.html

Form SCHEDULE 13G/A GE HealthCare Technologi Filed by: DODGE & COX

Thu, 14 May 2026 12:42:00 -0400

si-local-file:///var/storage/secattach/20260514/26492818.html

Form SCHEDULE 13G/A GE HealthCare Technologi Filed by: Capital Research Global Investors

Thu, 14 May 2026 10:20:00 -0400

si-local-file:///var/storage/secattach/20260514/26491761.html

Form SCHEDULE 13G/A GE HealthCare Technologi Filed by: Capital Research Global Investors

Thu, 14 May 2026 10:20:00 -0400

si-local-file:///var/storage/secattach/20260514/26491761.html

Form 4 GE HealthCare Technologi For: May 12 Filed by: Hochman Rodney F

Wed, 13 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260513/26486375.html

Form 4 GE HealthCare Technologi For: May 12 Filed by: Hochman Rodney F

Wed, 13 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260513/26486375.html

Form 4 GE HealthCare Technologi For: May 12 Filed by: Hochman Rodney F

Wed, 13 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260513/26486375.html

ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions

Tue, 12 May 2026 09:00:00 -0400

The company will showcase the latest iRT solution, MIM software innovations, and BK Medical technology – advancing speed, connectivity, and personalized medicine across the cancer care pathway.

CHICAGO--(BUSINESS WIRE)-- At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare (Nasdaq: GEHC) will highlight a portfolio of AI-enabled solutions designed to support clinicians across radiation therapy, theranostics, and image-guided interventions. The company’s presence underscores its focus on reducing workflow complexity, improving coordination across departments, and enabling more timely and personalized cancer care.

According to the World Health Organization, cancer accounts for nearly 10 million

ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions

Tue, 12 May 2026 09:00:00 -0400

The company will showcase the latest iRT solution, MIM software innovations, and BK Medical technology – advancing speed, connectivity, and personalized medicine across the cancer care pathway.

According to the World Health Organization, cancer accounts for nearly 10 million

ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions

Tue, 12 May 2026 09:00:00 -0400

The company will showcase the latest iRT solution, MIM software innovations, and BK Medical technology – advancing speed, connectivity, and personalized medicine across the cancer care pathway.

According to the World Health Organization, cancer accounts for nearly 10 million